Inhibition of B-Cell activation by retinal pigment epithelium

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 11, 2010, Pages 5783-5788

  Sugita, Sunao ^a   Horie, Shintaro ^a   Yamada, Yukiko ^a   Mochizuki, Manabu ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; LIPOPOLYSACCHARIDE; RECOMBINANT INTERLEUKIN 4; TRANSFORMING GROWTH FACTOR BETA ANTIBODY;

ANIMAL CELL; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE ACTIVATION; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; MOUSE; NONHUMAN; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PURIFICATION; UPREGULATION;

ANIMALS; ANTIGENS, CD40; B-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOSUPPRESSION; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; RETINAL PIGMENT EPITHELIUM; TRANSFORMING GROWTH FACTOR BETA;

EID: 79956059532     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-5098     Document Type: Article

References (40)

1. Kakiuchi T, Chesnut RW, Grey HM. B cells as antigen-presenting cells: the requirement for B cell activation. J Immunol. 1983;131: 109-114.
2. Paul WE, Ohara J. B-cell stimulatory factor-1/interleukin 4. Annu Rev Immunol. 1987;5:429-459.
3. Ranheim EA, Kipps TJ. Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. J Exp Med. 1993;177:925-935.
4. Chan CC, Nussenblatt RB, Fujikawa LS, et al. Sympathetic ophthalmia: immunopathological findings. Ophthalmology. 1986; 93:690-695.
5. Tuaillon N, Chan CC. Molecular analysis of primary central nervous system and primary intraocular lymphomas. Curr Mol Med. 2001; 1:259-272.
6. Meunier J, Lumbroso-Le Rouic L, Vincent-Salomon A, et al. Ophthalmologic and intraocular non-Hodgkin's lymphoma: a large single centre study of initial characteristics, natural history, and prognostic factors. Hematol Oncol. 2004;22:143-158.
7. Peek R, Verjans GM, Meek B. Herpes simplex virus infection of the human eye induces a compartmentalized virus-specific B cell response. J Infect Dis. 2002;186:1539-1546.
8. Wang HM, Sheu MM, Stulting RD, et al. Immunohistochemical evaluation of murine HSV-1 keratouveitis. Curr Eye Res. 1989;8: 37-46.
9. Sugita S, Streilein JW. Iris pigment epithelium expressing CD86 (B7-2) directly suppresses T cell activation in vitro via binding to cytotoxic T lymphocyte-associated antigen 4. J Exp Med. 2003; 198:161-171.
10. Sugita S, Futagami Y, Smith SB, et al. Retinal and ciliary body pigment epithelium suppress activation of T lymphocytes via transforming growth factor beta. Exp Eye Res. 2006;83:1459-1471.
11. Sugita S, Usui Y, Horie S, et al. T-cell suppression by programmed cell death 1 ligand 1 on retinal pigment epithelium during inflammatory conditions. Invest Ophthalmol Vis Sci. 2009;50:2862-2870.
12. Sugita S, Horie S, Nakamura O, et al. Retinal pigment epitheliumderived CTLA-2alpha induces TGFβ-producing T regulatory cells. J Immunol. 2008;181:7525-7536.
13. Ishida K, Panjwani N, Cao Z, et al. Participation of pigment epithelium in ocular immune privilege, 3: epithelia cultured from iris, ciliary body, and retina suppress T-cell activation by partially nonoverlapping mechanisms. Ocul Immunol Inflamm. 2003;11:91-105.
14. Liversidge J, McKay D, Mullen G, et al. Retinal pigment epithelial cells modulate lymphocyte function at the blood-retina barrier by autocrine PGE2 and membrane-bound mechanisms. Cell Immunol.1993;149:315-330.
15. Zamiri P, Masli S, Kitaichi N, et al. Thrombospondin plays a vital role in the immune privilege of the eye. Invest Ophthalmol Vis Sci.2005;46:908-919.
16. Sugita S, Ng TF, Schwartzkopff J, et al. CTLA-4+CD8+ T cells that encounter B7-2+ iris pigment epithelial cells express their own B7-2 to achieve global suppression of T cell activation. J Immunol.2004;172:4184-4194.
17. Clark EA. CD40: a cytokine receptor in search of a ligand. Tissue Antigens. 1990;36:33-36.
18. Kaneko Y, Hirose S, Abe M, et al. CD40-mediated stimulation of B1 and B2 cells: implication in autoantibody production in murine lupus. Eur J Immunol. 1996;26:3061-3065.
19. Sugita S, Ng TF, Lucas PJ, et al. B7+ iris pigment epithelium induce CD8+ T regulatory cells; both suppress CTLA-4+ T cells. J Immunol.2006;176:118-127.
20. Yazawa N, Fujimoto M, Sato S, et al. CD19 regulates innate immunity by the toll-like receptor RP105 signaling in B lymphocytes. Blood. 2003;102:1374-1380.
21. Wagner M, Poeck H, Jahrsdoerfer B, et al. IL-12p70-dependent Th1 induction by human B cells requires combined activation with CD40 ligand and CpG DNA. J Immunol. 2004;172:954-963.
22. Lin SC, Stavnezer J. Activation of NF-κB/Rel by CD40 engagement induces the mouse germ line immunoglobulin Cγ1 promoter. Mol Cell Biol. 1996;16:4591-4603.
23. Lane P, Traunecker A, Hubele S, et al. Activated human T cells express a ligand for the human B cell-associated antigen CD40 which participates in T cell-dependent activation of B lymphocytes. Eur J Immunol. 1992;22:2573-2578.
24. Jelinek DF. Regulation of B lymphocyte differentiation. Ann Allergy Asthma Immunol. 2000;84:375-385.
25. Valle A, Zuber CE, Defrance T, et al. Activation of human B lymphocytes through CD40 and interleukin 4. Eur J Immunol.1989;19:1463-1467.
26. Streilein JW. Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nat Rev Immunol. 2003;3:879-889.
27. Sugita S. Role of ocular pigment epithelial cells in immune privilege. Arch Immunol Ther Exp (Warsz). 2009;57:263-268.
28. Shalaby MR, Ammann AJ. Suppression of immune cell function in vitro by recombinant human transforming growth factor-beta. Cell Immunol. 1988;112:343-350.
29. Petit-Koskas E, Génot E, Lawrence D, Kolb JP. Inhibition of the proliferative response of human B lymphocytes to B cell growth factor by transforming growth factor-beta. Eur J Immunol. 1988; 18:111-116.
30. van den Wall Bake AW, Black KP, Kulhavy R, Mestecky J, Jackson S. Transforming growth factor-beta inhibits the production of IgG, IgM, and IgA in human lymphocyte cultures. Cell Immunol. 1992; 144:417-428.
31. Spender LC, O'Brien DI, Simpson D, et al. TGF-beta induces apoptosis in human B cells by transcriptional regulation of BIK and BCL-XL. Cell Death Differ. 2009;16:593-602.
32. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392:245-252.
33. Sugita S, Horie S, Nakamura O, et al. Acquisition of T regulatory function in cathepsin L-inhibited T cells by eye-derived CTLA-2α during inflammatory conditions. J Immunol. 2009;183:5013-5022.
34. Futagami Y, Sugita S, Vega J, et al. Role of thrombospondin-1 in T cell response to ocular pigment epithelial cells. J Immunol. 2007; 178:6994-7005.
35. Bouaziz JD, Yanaba K, Tedder TF. Regulatory B cells as inhibitors of immune responses and inflammation. Immunol Rev. 2008;224: 201-214.
36. Matsushita T, Yanaba K, Bouaziz JD, et al. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J Clin Invest. 2008;118:3420-3430.
37. Mauri C, Gray D, Mushtaq N, Londei M. Prevention of arthritis by interleukin 10-producing B cells. J Exp Med. 2003;197:489-501.
38. Popi AF, Lopes JD, Mariano M. Interleukin-10 secreted by B-1 cells modulates the phagocytic activity of murine macrophages in vitro. Immunology. 2004;113:348-354.
39. Cousins SW, McCabe MM, Danielpour D, Streilein JW. Identification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor. Invest Ophthalmol Vis Sci. 1991;32: 2201-2211.
40. Granstein RD, Staszewski R, Knisely TL, et al. Aqueous humor contains transforming growth factor-beta and a small (less than 3500 daltons) inhibitor of thymocyte proliferation. J Immunol.1990;144:3021-3027.